2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Cancer genetics<br />
genesis and cancer progression . Mutations in TP53 are considered to<br />
represent the most common genetic alteration and occur in about 50%<br />
<strong>of</strong> human cancers . These mutations may damage the normal function<br />
<strong>of</strong> p53 as a transcription factor and the induction <strong>of</strong> repair or apoptosis<br />
may be diminished . Consequently, genetic alterations may accumulate<br />
in the cell .<br />
Evidences from previous studies imply that there is a clear correlation<br />
between mutational status <strong>of</strong> TP53 and expression <strong>of</strong> gens down the<br />
p53-signaling pathway .<br />
We examined the impact <strong>of</strong> mutations in DNA binding domain <strong>of</strong> p53<br />
on expression <strong>of</strong> genes involved in cell cycle arrest, particularly CDK4<br />
and its inhibitor CDKN2 .<br />
This study included bioptic samples from 80 breast and colon cancer<br />
affected subjects with different malignancy grades .<br />
To test hypothesis that mutation in TP53 can influence expression <strong>of</strong><br />
CDK4 and CDKN2, TP53 has been subjected to mutational analysis<br />
by RFLP followed by sequencing .<br />
Expression <strong>of</strong> genes involved in cell cycle arrest was measured using<br />
SYBR-green based real-time PCR .<br />
Mutations in TP53 were detected in 8% <strong>of</strong> the examined cases .<br />
We compared expressions <strong>of</strong> CDK4 and CDKN2 in the samples that<br />
harbor a mutation to those without mutations .<br />
Pathohistological findings obtained from clinic were correlated with<br />
molecular alterations .<br />
P04.203<br />
Association study <strong>of</strong> codon 10 polymorphism <strong>of</strong> the<br />
Transforming growth factor-beta 1 (TGF-β1) gene with prostate<br />
cancer and hyperplasia<br />
M. Omrani, S. Bazargani, S. Salari, B. Farshid;<br />
Uromieh Medical Science University, Uromieh, Islamic Republic <strong>of</strong> Iran.<br />
Introduction: Transforming growth factor-beta 1 (TGF-β1) has a multifactorial<br />
role in the development <strong>of</strong> cancer . Genetic polymorphisms<br />
in codons 10 <strong>of</strong> the TGF-β1 gene have been shown to be associated<br />
with the production <strong>of</strong> high or low TGF-β1 levels. The role <strong>of</strong> this polymorphism<br />
in development <strong>of</strong> prostate cancer and hyperplasia was investigated<br />
.<br />
Material and Methods:Using ASO-PCR method, association between<br />
the T (Leu) to C (Pro) polymorphism at codon10 <strong>of</strong> the TGF-ß1 gene<br />
(TGFB1) and the risk <strong>of</strong> PCa or BPH in 100 controls were determined<br />
.<br />
Results: Significant differences in the CC versus TT genotype distribution<br />
between PCa patients and male controls (P = 0 .009), and between<br />
BPH patients and male controls (P = 0 .005) were noticed . Males with<br />
the TT genotype had a 1.67-fold increased risk <strong>of</strong> PCa [95% confidence<br />
interval (95% CI) = 1 .49-1 .87, P = 0 .009] and TC /TT genotype,<br />
1.14-fold increased risk <strong>of</strong> PCa [95% confidence interval (95% CI) =<br />
1 .02-1 .26, P = 0 .047] and a 1 .54-fold increased risk <strong>of</strong> BPH with the<br />
TT genotype (95% CI = 0 .98-1 .14, P = 0 .005) and 1 .06-fold increased<br />
risk <strong>of</strong> BPH with the TT/TC genotype (95% CI = 0 .98-1 .14, P = 0 .061)<br />
compared with those with the CC genotype respectively .<br />
Conclusion: Based on our findings, it was possible to conclude that the<br />
codon10 polymorphism in TGFB1 may have a significant influence on<br />
the development <strong>of</strong> PCa and BPH and the T allele <strong>of</strong> TGFB1gene has<br />
the dominant effect on development <strong>of</strong> PCa and BPH .<br />
P04.204<br />
subtle microsatellite instability in pediatric gliomas as an<br />
indicator <strong>of</strong> type 1 turcot syndrome<br />
L. Giunti 1 , V. Cetica 2 , U. Ricci 1 , S. Giglio 3 , I. Sardi 2 , M. Paglierani 4 , A. Buccoliero<br />
4 , L. Genitori 5 , M. Genuardi 3,1,4 ;<br />
1 Medical <strong>Genetics</strong> Unit, Meyer Children’s University Hospital, Florence, Italy,<br />
2 Department <strong>of</strong> Pediatrics, University <strong>of</strong> Florence, Florence, Italy, 3 Medical<br />
<strong>Genetics</strong> Unit, Department <strong>of</strong> Clinical Pathophysiology, Florence, Italy, 4 Department<br />
<strong>of</strong> Biomedicine, Careggi University Hospital, Florence, Italy, 5 Neurosurgery<br />
Unit, Meyer Children’s University Hospital, Florence, Italy.<br />
Type 1 Turcot syndrome (TS1) is characterized by the association <strong>of</strong><br />
early-onset glial and colorectal tumors and is caused by mutations <strong>of</strong><br />
the mismatch repair genes . To determine the role <strong>of</strong> genetic predisposition<br />
in glial tumor development, we investigated the frequency <strong>of</strong><br />
microsatellite instability (MSI) in a series <strong>of</strong> 38 pediatric gliomas using<br />
a panel <strong>of</strong> 5 quasimonomorphic mononucleotide markers . A pattern <strong>of</strong><br />
“subtle” MSI for most tested markers was observed in 2 glioblastomas .<br />
In both cases family history was indicative <strong>of</strong> TS1, as confirmed by the<br />
detection <strong>of</strong> mutations in the PMS2 and MLH1 genes . In one case,<br />
instability was revealed in diluted DNA samples . Comparison <strong>of</strong> the<br />
MSI patterns in normal (leukocyte and intestinal mucosa) and tumor<br />
(glioblastoma and colorectal cancer) samples from one TS1 family<br />
revealed that allelic size shifts were smaller in gliomas . Our results<br />
indicate that MSI analysis is an important tool to identify TS1-related<br />
pediatric gliomas, and that the pattern <strong>of</strong> microsatellite alterations in<br />
gliomas is less pronounced compared to colorectal cancer<br />
P04.205<br />
Analysis <strong>of</strong> the molecular genetic changes in uveal melanoma<br />
I. K. Manokhina 1 , N. V. Sklyarova 2 , S. V. Saakyan 2 , D. V. Zaletaev 1 ;<br />
1 Laboratory <strong>of</strong> human molecular genetics, Institute <strong>of</strong> Molecular Medicine, I.M.<br />
Sechenov Moscow Medical Academy, Moscow, Russian Federation, 2 Ophthalmo-oncology<br />
and radiology department, Helmholts Moscow Research Institute<br />
<strong>of</strong> Eye Diseases, Moscow, Russian Federation.<br />
Uveal melanoma (UM) is the most common primary cancer <strong>of</strong> the eye<br />
and has a strong predilection for hematogenous metastasis, particularly<br />
to the liver. Investigation <strong>of</strong> the specific genetic mechanisms responsible<br />
for the malignant behavior <strong>of</strong> UM could play an important role for<br />
the development <strong>of</strong> new approaches to UM diagnosis and treatment .<br />
We investigated 105 UM for allelic losses at chromosomal regions 3p,<br />
3q, 1p, 9p23, 10q23, 13q14, close or within some tumor suppressor<br />
genes (VHL, FHIT, RASSF1A, CDKN2A, PTEN, RB1) . Moreover, we<br />
investigated the methylation status <strong>of</strong> the promoter regions <strong>of</strong> these<br />
genes .<br />
45 UM (43%) had LOH at all informative loci <strong>of</strong> chromosome 3, indicating<br />
<strong>of</strong> monosomy 3 . Methylation analysis discovered frequent methylation<br />
<strong>of</strong> RASSF1A (24 patients, 23%), located at 3p21 .3 and inactivated<br />
in a large number <strong>of</strong> human cancers . Important to notice, methylation<br />
<strong>of</strong> RASSF1A was found predominantly in UM without monosomy 3 (20<br />
patients). These findings could reinforce the role <strong>of</strong> RASSF1A in the<br />
pathogenesis <strong>of</strong> UM .<br />
LOH at 1p was found in 28 samples mainly at all informative loci (5 MS<br />
markers, 1p31 .3 to 1p36 .3) without any relation to the monosomy 3 .<br />
Five samples had partial allelic losses at 1p31 .3 or 1p36 .3 . 1p contains<br />
wide range <strong>of</strong> TSGs, and for the moment we could not identify those<br />
who might be candidate genes for the UM .Additionally, we conclude<br />
that inactivation <strong>of</strong> the regulation pathway CDKN2A→RB1 with promoter<br />
methylation or LOH is not the major mechanism <strong>of</strong> the pathogenesis<br />
in UM unlike cutaneous melanoma .<br />
P04.206<br />
VANGL1 effects cell invasion rather than cell motility<br />
O. Cetin 1 , A. Toylu 2 , N. Atabey 2 , Z. Sercan 2 , M. Sakizli 2 ;<br />
1 Pamukkale University, School <strong>of</strong> Medicine, Department <strong>of</strong> Medical Biology,<br />
Denizli, Turkey, 2 Dokuz Eylul University, School <strong>of</strong> Medicine, Department <strong>of</strong><br />
Medical Biology and <strong>Genetics</strong>, Izmir, Turkey.<br />
Van Gogh like 1 (Vangl1) is a transmembrane protein on Wnt planar cell<br />
polarity pathway . It has an important role in planar cell polarity and convergent<br />
extension in embryonic development . In adults, it is expressed<br />
specifically in testis and ovaries as well as in brain and prostate.VANGL1<br />
expression has been shown in several human cancer cell lines including<br />
hepatocellular carcinoma (HCC) . Our aim in this study was to investigate<br />
the changes in the behaviour <strong>of</strong> the HCC cells whose VANGL1 gene was<br />
silenced by siRNA .<br />
VANGL1 expression in HCC cell lines was shown by RT-PCR and real<br />
time PCR. The siRNA template which will transcribe the specific hairpin<br />
siRNA for VANGL1 gene was designed following the determination <strong>of</strong> the<br />
target sequence . The siRNA template was ligated to a siRNA expression<br />
vector and HepG2 cells were transfected . The colonies expressing the<br />
siRNA were detected by RT-PCR, quantitative RT-PCR and Western blotting<br />
. Motility and invasion <strong>of</strong> the cells were assessed by Boyden chamber<br />
assay while cell cycle analysis was performed by flow cytometry.<br />
The motility <strong>of</strong> the cells was not effected with gene silencing while there<br />
was a three fold decrease in the invasion potential <strong>of</strong> the cells expressing<br />
the siRNA. The proliferation assay revealed no significant difference<br />
between the transfected cells and parental cells with regard to S phase<br />
cell ratio .<br />
In conclusion, VANGL1 gene has an effect on cell invasion rather than<br />
cell motility . Further investigations are needed to understand the mechanisms<br />
<strong>of</strong> this effect .